MarketPeel
Insider Trading Intelligence
JD

John Brendan Doyle

CGTX
CHIEF FINANCIAL OFFICER · COGNITION THERAPEUTICS INC · CIK 0001840738
FILING MIX · LIFETIME53%/47%
BUYS
9
SELLS
8
TOTAL VALUE
$94.4K
COMPANIES
1
ACTIVE SINCE
May 2023
HOLDINGS NOW
618,942
AVG SELL PX
$1.09
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by John Brendan Doyle, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+13.51%+0.97%+12.55%+12.55%
14d1+100.00%+13.51%+2.42%+11.09%+11.09%
30d1+100.00%+7.22%+5.79%+1.42%+1.42%
60d1+100.00%+9.01%+5.71%+3.29%+3.29%
90d1(1 pending)
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CGTX · 618,942 shares · as of May 1, 2026
0161,498322,995484,493645,990202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 8 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
8,567$1.28$11.0K618,942May 1, 2026May 4, 2026View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
Chief Financial Officer
10,000$1.13$11.3K627,509Apr 16, 2026Apr 20, 2026View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
1,560$1.12$1.7K617,509Feb 15, 2026Feb 18, 2026View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
26,921$1.03$27.7K619,069Feb 4, 2026Feb 5, 2026View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
200,000645,990Feb 3, 2026Feb 5, 2026View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
30,000455,350Dec 18, 2025Dec 22, 2025View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
9,360$1.50$14.0K445,990Dec 18, 2025Dec 22, 2025View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
30,000434,710Jul 29, 2025Jul 31, 2025View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
9,360$0.67$6.3K425,350Jul 29, 2025Jul 31, 2025View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
9,692$0.45$4.3K404,710May 1, 2025May 2, 2025View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
1,723$0.59$1.0K414,402Feb 15, 2025Feb 18, 2025View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
295,000416,125Feb 4, 2025Feb 4, 2025View →
CGTX
COGNITION THERAPEUTICS INC
SALE
Chief Financial Officer
8,699$1.95$17.0K121,125May 1, 2024May 3, 2024View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
20,00020,000Feb 15, 2024Feb 20, 2024View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
20,000129,824Feb 15, 2024Feb 20, 2024View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
109,824109,824May 1, 2023May 3, 2023View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
109,824109,824May 1, 2023May 3, 2023View →
Other insiders · CGTX
Loading peer insiders…
About this filer
CIK 0001840738
ROLE
Chief Financial Officer
PRIMARY
CGTX
COMPANIES
1
ACTIVE SINCE
May 2023
MARKETPEEL · /INSIDER/0001840738DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback